Shed vs Maximus: Coaching and Pricing Compared for GLP-1 Care
Shed vs Maximus: which telehealth GLP-1 option fits you? Quick verdict: Shed focuses on combining name-brand and compounded GLP-1 with integrated coaching and a 10% first-month offer, while Maximus prioritizes a low, flat compounded semaglutide price of $132.99 per month via telemedicine.
Explore Shed’s name-brand and compounded options
How the two platforms differ at a glance
This comparison uses only supplied facts to contrast Shed and Maximus across the most distinctive differences: medication mix and regulatory notes, coaching and care model, price structure and transparency, pharmacy sourcing and state availability, and onboarding speed and guarantees.
1. Medication options and regulatory status
Shed: Offers both FDA-approved name-brand GLP-1 and compounded options on one platform, and the source explicitly states “compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality.” Maximus: Offers compounded semaglutide only; the source also notes that compounded medication is used and is not an FDA-approved finished product.
See Maximus semaglutide pricing and protocol
2. Coaching and care model
Shed: Integrates continuous coaching into treatment rather than simply issuing a prescription; coaching is bundled into the treatment plan. Maximus: Positions itself as a straightforward telemedicine model with prescriptions approved by licensed doctors and filled through trusted U.S. pharmacies, but does not advertise integrated continuous coaching in the supplied evidence.
3. Price structure and transparency
Maximus: Advertises a low flat rate at $132.99 per month for compounded semaglutide and emphasizes no membership fees and transparent pricing. Shed: Lists compounded semaglutide starting at $199/month and compounded tirzepatide starting at $299/month, and notes a 10% off first-month offer; Shed does not publish a single standard price and provides personalized quotes after intake.
Get Shed pricing details and 10% off first month
4. Pharmacy sourcing, approvals, and availability
Maximus: Fills prescriptions through trusted U.S. pharmacies, prescribes via licensed doctors, and the Weight Loss Protocol is available in all 50 states except Mississippi. Shed: Medications, including compounded options, are prepared by a licensed pharmacy based on a provider’s prescription and are only issued after a clinician review that determines medical appropriateness.
5. Onboarding speed and refund or guarantee notes
Shed: Uses a 2-minute approval assessment to check eligibility quickly; a licensed provider reviews the case before issuing a prescription. Maximus: If you are not approved for treatment, the source states medication costs will be fully refunded and offers telemedicine access without in-person visits.
| Criteria | Shed | Maximus |
|---|---|---|
| Medication options | FDA-approved name-brand and compounded GLP-1 options | Compounded semaglutide only |
| Regulatory note | Compounded medications are not FDA-approved and are not reviewed by FDA | Compounded medication not an FDA-approved finished product |
| Coaching | Continuous coaching integrated into treatment | No continuous coaching advertised in supplied evidence |
| Starting price | Compounded semaglutide starting at $199/month; tirzepatide starting at $299/month; 10% off first month | $132.99/month flat rate for semaglutide |
| Pharmacy sourcing | Compounded medications prepared by a licensed pharmacy per prescription | Filled through trusted U.S. pharmacies; prescriptions approved by licensed doctors |
| Availability and policy | Prescription issued only after clinician review; eligibility checked via 2-minute assessment | Available in all 50 states except Mississippi; refund if not approved for treatment |
What this means for different users
If you want a platform that pairs medication with behavioral support and offers both branded and compounded choices, Shed is the supplier described as integrating continuous coaching and offering both medication types, with a quick 2-minute eligibility check. If your priority is the lowest advertised monthly price and a simple telemedicine path to compounded semaglutide, Maximus presents a low flat $132.99/month option filled by U.S. pharmacies with licensed-doctor approvals and statewide availability except Mississippi.
Start Maximus enrollment and telemedicine visit
Final comparison and recommendation
Both platforms use clinician review before prescribing and both rely on compounded medication options that are not FDA-approved as finished products. The primary trade-off is coaching and choice versus lower flat pricing and streamlined telemedicine access. Use the primary keyword to compare practical fit: Shed vs Maximus.
Choose Shed if you want name-brand options plus bundled, continuous coaching and are willing to get a personalized quote and use a platform that offers a 10% off introductory month. Choose Maximus if you want a low flat-rate compounded semaglutide program at $132.99 per month with prescriptions filled through U.S. pharmacies and simple telemedicine access.